Tag Archives: Severe

FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia

FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia Print this page CHICAGO–(BUSINESS WIRE)–Sep. 10, 2019– Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received regulatory approval from the U.S.… Read More »

FDA Approves Osphena (ospemifene) for Moderate to Severe Vaginal Dryness Due to Menopause

Print this page BLAINVILLE, QC, January 29, 2019 – Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced today that the FDA has approved its supplemental New Drug Application (sNDA) seeking to add moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy (VVA), due to menopause, to the indication of Osphena… Read More »

In Brief: Improving Care for New Mothers with Severe Psychiatric Illness

NPR just aired a short story about a young woman who experienced postpartum psychosis after the birth of her first child.  It was a short article but it brought up several important themes. The article highlights the importance of recognizing postpartum psychosis. While we have worked hard to increase awareness of postpartum depression, the article… Read More »